je.st
news
Tag: msd
MSD Animal Health to Acquire Worldwide Rights to Whisper Veterinary Stethoscope System
2016-04-25 02:00:00| ThePigSite - Industry News
GLOBAL - MSD Animal Health (known as Merck Animal Health inside the United States and Canada) today announced plans to acquire worldwide rights for the Whisper® Veterinary Stethoscope System from Minnesota-based Geissler Companies.
Tags: rights
system
health
worldwide
MSD Animal Health Receives Positive Final Opinion from European Medicines Agency for BRAVECTO (fluralaner) Spot-On for Cats and Dogs
2016-03-22 09:00:00| Merck.com - Corporate News
Dateline City: MADISON, N.J. Only Spot-On Treatment for Fleas and Ticks Effective For 12 Weeks MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has adopted a positive final opinion, recommending the granting of a marketing authorization for the veterinary medicinal product BRAVECTO (fluralaner) Spot-On for both cats and dogs. Language: English Contact: MSD Animal HealthMedia:Amy Firsching, +1-908-473-6357amy.firsching@merck.comorPam Eisele, +1-908-423-5042pamela_eisele@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: health
final
positive
opinion
MSD Animal Health Introduces PORCILISÂ PCV ID at 2016 High Quality Pork Congress
2016-03-17 01:00:00| ThePigSite - Industry News
PORTUGAL - On February 4-5, MSD Animal Health held its 2016 High Quality Pork Congress in Lisbon, Portugal, bringing together swine producers and veterinarians from across Europe to discuss the benefits of needle-free intradermal vaccinations for both pigs and producers.
Tags: high
health
quality
high quality
Sanofi Pasteur and Merck (Known as MSD Outside the United States and Canada) Announce Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies
2016-03-08 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. & LYON, France KENILWORTH, N.J. & LYON, France--(BUSINESS WIRE)--Sanofi Pasteur and Merck, known as MSD outside the United States and Canada, today announced their intent to end their joint vaccines operations in Europe. Upon concluding their joint venture, both companies plan to integrate their respective European vaccine businesses into their operations, independently manage their product portfolios and pursue their own distinct growth strategies in Europe. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestor:Justin Holko, 908-740-1879orSanofi PasteurMedia:Alain Bernal, +33 4 37 37 50 38orInvestor:Sébastien Martel, +33 1 53 77 45 45 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: SAN Exchange: BOURSE Ticker: SNY Exchange: NYSE read more
MSD Launches First Intradermal Vaccine Against PCV2
2016-02-16 01:00:00| ThePigSite - Industry News
PORTUGAL – MSD Animal Health held the High Quality Pork Congress on 4th and 5th February in order to present the lastest state-of-the-art intradermal vaccine against PCV2: PORCILIS PCV ID.
Tags: launches
vaccine
msd
pcv2